DO Dow Jones Newswires Vertex Pharmaceuticals Sees Crinetics Deal Helping Non-GAAP Operating Income in 2029 >VRTX 7/7/2026, 04:08 am GMT+8 Dow Jones Newswires CR CRNX VR VRTX Sources Dow Jones Newswires Markets Stocks Active symbols NASDAQ:CRNX, NASDAQ:VRTX Language English (India) Vertex Pharmaceuticals Sees Crinetics Deal Helping Non-GAAP Operating Income in 2029 >VRTX Market News PR Newswire Are ESI, CRNX, SOLS Obtaining Fair Deals for their Shareholders? FinanceWire The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush PR Newswire The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy Stocktwits VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?
